Literature DB >> 15663182

The age-related increase in N-methyl-2-pyridone-5-carboxamide (NAD catabolite) in human plasma.

Ewa M Slominska1, Przemyslaw Rutkowski, Ryszard T Smolenski, Andrzej Szutowicz, Boleslaw Rutkowski, Julian Swierczynski.   

Abstract

N-Methyl-2-pyridone-5-carboxamide (2PY) is a major catabolite of NAD, which is excreted in the urine. Assay of plasma concentration and urine exrection of 2PY is of interest for monitoring niacin nutritional state and NAD catabolism. Aging has major impact on number of metabolic processes, but its effect on plasma and tissue 2PY concentration has not been studied so far. The present study was undertaken to investigate the effect of aging on human plasma 2PY concentration. Blood samples were collected from 78 (56 females and 22 males) healthy subjects at different age ranging from 5 to 90 years. Plasma ultrafiltrates were analyzed with liquid chromatography/mass spectrometry (LC/MS) for 2PY concentration. 2PY concentration was also evaluated in plasma and liver of young (2 month) and old (24 month) rats. The mean plasma 2PY concentration in young (5-16 years old) healthy subjects was 0.39 +/- 0.22 micromol/l while in old healthy subjects (50-90 years old) it was approximately 2.6-fold higher. No gender differences was found in plasma 2PY concentration. Univariate regression analysis displayed positive correlation between age and human plasma 2PY concentration (r = 0.57, p < 0.01) and between age and 2PY/creatinine ratio (r = 0.4, p < 0.01). Multivariate regression analysis indicates that both age and plasma creatinine concentrations were independently correlated with the increase in plasma 2PY concentration. Daily 2PY excretion with urine corrected for weight was approximately 30% lower in old subjects than in young humans. 2PY concentrations in liver and plasma of 2-month-old rats were lower than in 24-month-old rats. In conclusion, our results demonstrated that human plasma 2PY concentration increases with age. This could be a consequence of both decreased renal excretion and increased production in the the liver or other organs. Our results indicate that age should be taken into consideration in the interpretation of plasma 2PY concentration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15663182     DOI: 10.1023/b:mcbi.0000049359.66669.29

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  25 in total

Review 1.  Poly(ADP-ribose) polymerase in the cellular response to DNA damage, apoptosis, and disease.

Authors:  F J Oliver; J Menissier-de Murcia; G de Murcia
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

2.  The involvement of poly(ADP-ribose) polymerase in the degradation of NAD caused by gamma-radiation and N-methyl-N-nitrosourea.

Authors:  C J Skidmore; M I Davies; P M Goodwin; H Halldorsson; P J Lewis; S Shall; A A Zia'ee
Journal:  Eur J Biochem       Date:  1979-11-01

3.  Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion.

Authors:  H C Ha; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

Review 4.  Physiological functions of cyclic ADP-ribose and NAADP as calcium messengers.

Authors:  H C Lee
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

5.  Fluorometric assay of rat brain N-methyltransferase with 4-methylnicotinamide.

Authors:  A Sano; N Endo; S Takitani
Journal:  Biol Pharm Bull       Date:  1993-03       Impact factor: 2.233

Review 6.  Gout, uric acid and purine metabolism in paediatric nephrology.

Authors:  J S Cameron; F Moro; H A Simmonds
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714

7.  Poly(ADP-ribose) polymerase activity in mononuclear leukocytes of 13 mammalian species correlates with species-specific life span.

Authors:  K Grube; A Bürkle
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  Origin and characteristics of an unusual pyridine nucleotide accumulating in erythrocytes: positive correlation with degree of renal failure.

Authors:  Elizabeth A Carrey; Ryszard T Smolenski; Stephen M Edbury; Arian Laurence; Anthony M Marinaki; John A Duley; Limin Zhu; David J A Goldsmith; H Anne Simmonds
Journal:  Clin Chim Acta       Date:  2003-09       Impact factor: 3.786

9.  High-performance liquid chromatographic determination of nicotinamide and its metabolites in human and murine plasma and urine.

Authors:  M R Stratford; M F Dennis
Journal:  J Chromatogr       Date:  1992-11-06

10.  Correlation between niacin equivalent intake and urinary excretion of its metabolites, N'-methylnicotinamide, N'-methyl-2-pyridone-5-carboxamide, and N'-methyl-4-pyridone-3-carboxamide, in humans consuming a self-selected food.

Authors:  K Shibata; H Matsuo
Journal:  Am J Clin Nutr       Date:  1989-07       Impact factor: 7.045

View more
  4 in total

Review 1.  COVID-19: Are We Facing Secondary Pellagra Which Cannot Simply Be Cured by Vitamin B3?

Authors:  Renata Novak Kujundžić
Journal:  Int J Mol Sci       Date:  2022-04-13       Impact factor: 6.208

2.  4-Pyridone-3-carboxamide-1-β-D-ribonucleoside triphosphate (4PyTP), a novel NAD metabolite accumulating in erythrocytes of uremic children: a biomarker for a toxic NAD analogue in other tissues?

Authors:  Elena Synesiou; Lynnette D Fairbanks; H Anne Simmonds; Ewa M Slominska; Ryszard T Smolenski; Elizabeth A Carrey
Journal:  Toxins (Basel)       Date:  2011-06-07       Impact factor: 4.546

Review 3.  N-methyl-2-pyridone-5-carboxamide (2PY)-Major Metabolite of Nicotinamide: An Update on an Old Uremic Toxin.

Authors:  Aurélie Lenglet; Sophie Liabeuf; Sandra Bodeau; Loïc Louvet; Aurélien Mary; Agnès Boullier; Anne Sophie Lemaire-Hurtel; Alexia Jonet; Pascal Sonnet; Said Kamel; Ziad A Massy
Journal:  Toxins (Basel)       Date:  2016-11-15       Impact factor: 4.546

4.  The Biochemical Pathways of Nicotinamide-Derived Pyridones.

Authors:  Faisal Hayat; Manoj Sonavane; Mikhail V Makarov; Samuel A J Trammell; Pamela McPherson; Natalie R Gassman; Marie E Migaud
Journal:  Int J Mol Sci       Date:  2021-01-24       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.